I remember Prof Du Pont saying in Melbourne that a number of biotechs have fallen into trouble releasing data too early in the hope of helping their share price and it backfired on them. He was implying that IMU had to wait, as we moved through the higher cohorts in both the CF33 trials results would get better. The challenge was when do you release date. Do we release data on cohort 2 when 3 is looking much better and what about 4?
I remember Prof Du Pont saying in Melbourne that a number of...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
-0.004(5.33%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 7.5¢ | 7.5¢ | 6.8¢ | $2.847M | 40.20M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 266411 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 1022995 | 3 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.004 ( 6.17 %) |
||||
| Open | High | Low | Volume | ||
| 7.4¢ | 7.4¢ | 6.8¢ | 19590616 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| IMU (ASX) Chart |